Last deal

$34.M

Amount

Series B

Stage

02.04.2018

Date

2

all rounds

$72.M

Total amount

General

About Company
CMAB BioPharm is a biopharmaceutical service firm.

Industry

Sector :

Subsector :

Keywords :

Also Known As

CMAB Bio, Suqiao Biologics, Suqiao Biopharma

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Suqiao Bio is a Chinese biopharmaceutical custom development and production (CDMO) service company that offers a one-stop-shop for preclinical and clinical drug Phase I, Phase II, and Phase III biopharmaceutical products from DNA sequences to commercial production. The company specializes in cell line development research, aseptic drugs, and GMP manufacturing. Suqiao Bio provides various antibodies and biologics such as aseptic drugs and GMP for clients in China and across the globe through. Their services enable clients to receive various pre-clinical and early-stage clinical products from them while strictly adhering to the quality standards of domestic and international pharmaceutical production management regulations.